Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Lymphocytic Leukemia
100%
DNA Damage Response
100%
DNA Damage Repair
100%
Protein Expression Pattern
100%
Repair Proteins
42%
Overall Survival
28%
Survival Outcomes
28%
Expression Pattern
28%
Proteomics
14%
Cyclophosphamide
14%
Chemotherapy
14%
CD19
14%
DNA Damage
14%
Cell Signaling
14%
Poor Survival
14%
Patient Outcomes
14%
Fludarabine
14%
Poor Prognostic
14%
Cell Cycle Proteins
14%
PI3K Inhibitor
14%
Survival Response
14%
Low Expression
14%
Proteomic Expression
14%
MAPK Protein
14%
Adhesion Cell
14%
Patient Clustering
14%
Bcl-2 Inhibitor
14%
Repair Cell
14%
Modern Therapy
14%
Cell Adhesion Proteins
14%
Differential Expression Analysis
14%
Rituxan
14%
Time to First Treatment
14%
Medicine and Dentistry
Prognostication
100%
Protein Expression
100%
DNA Repair
100%
DNA Damage Response
100%
B-Cell Chronic Lymphocytic Leukemia
100%
Overall Survival
28%
extracellular signal regulated kinase
28%
Chronic Lymphocytic Leukemia
28%
Cyclophosphamide
14%
Proteomics
14%
Rituximab
14%
DNA Damage
14%
Cell Cycle
14%
Fludarabine
14%
Expression Analysis
14%
Cell Adhesion Proteins
14%
Cell Cycle Protein
14%
Signal Transduction
14%
Cell DNA
14%
Expression Proteomics
14%
Biochemistry, Genetics and Molecular Biology
DNA Repair
100%
Protein Expression
100%
DNA Damage Response
100%
Overall Survival
28%
extracellular signal regulated kinase
28%
Proteomics
14%
Cyclophosphamide
14%
Cell Cycle
14%
DNA Damage
14%
Expression Analysis
14%
Signal Transduction
14%
Fludarabine
14%
Expression Proteomics
14%
Rituximab
14%
Cell Cycle Protein
14%
CD19
14%
Cell Adhesion Molecule
14%